Market Cap

NextCell Pharma AB Market Capitalization:

kr90.4 Million

SEK as of Jan. 1, 2024

US$9.0 Million

business NextCell Pharma AB Company Profile

NextCell Pharma AB Main Stock Listing

OMX: NXTCL

Market Capitalization History of NextCell Pharma AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of NextCell Pharma AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr90.4 M -66.34%
Jan. 1, 2023 kr268.6 M -5.24%
Jan. 1, 2022 kr283.4 M -52.76%
Jan. 1, 2021 kr600.0 M 112.50%
Jan. 1, 2020 kr282.3 M 12.82%
Jan. 1, 2019 kr250.3 M 15.42%
Jan. 1, 2018 kr216.8 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

NextCell Pharma AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

NextCell Pharma AB has the following listings and related stock indices.


Stock: OMX: NXTCL

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.